Perfluorinated compounds are related to breast cancer risk in Greenlandic Inuit: A case control study

Environmental Health: A Global Access Science Source

Volumn 10, Issue 1, 2011, Pages

  Bonefeld Jorgensen, Eva C ^a   Long, Manhai ^a   Bossi, Rossana ^a   Ayotte, Pierre ^b   Asmund, Gert ^a   Krüger, Tanja ^a   Ghisari, Mandana ^a   Mulvad, Gert ^c   Kern, Peder ^c   Nzulumiki, Peter ^c   Dewailly, Eric ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^c Dronning Ingrids Hospital   (Greenland)

Author keywords

combined serum xenohormone and dioxin like activities; n 3 fatty acids; PFCs; POPs

Indexed keywords

ANDROGEN RECEPTOR; AROMATIC HYDROCARBON RECEPTOR; CADMIUM; ESTROGEN RECEPTOR; LEAD; MERCURY; ORGANIC COMPOUND; PERFLUORO COMPOUND; PERFLUORODECANOIC ACID; PERFLUORODODECANOIC ACID; PERFLUOROHEPTANOIC ACID; PERFLUOROHEXANE SULFONATE; PERFLUORONONANOIC ACID; PERFLUOROOCTANE SULFONAMIDE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; PERFLUOROTRIDECANOIC ACID; PERFLUOROUNDECANOIC ACID; POLYCHLORINATED BIPHENYL; SELENIUM; UNCLASSIFIED DRUG; ZINC; FLUOROCARBON; METAL;

CANCER; HEALTH RISK; HORMONE; LOGISTICS; ORGANIC POLLUTANT; PCB; REGRESSION ANALYSIS; RODENT; SAMPLING; SERUM; SPATIOTEMPORAL ANALYSIS; WOMENS HEALTH;

ADULT; ARTICLE; BLOOD LEVEL; BREAST CANCER; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; POLLUTANT; PRIORITY JOURNAL; ADOLESCENT; AGED; BLOOD; BREAST TUMOR; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ESKIMO; GREENLAND; METABOLISM; MIDDLE AGED; RISK;

ARCTIC; CANADA; GREENLAND;

RATTUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; GREENLAND; HUMANS; INUITS; METALS; MIDDLE AGED; RECEPTORS, ANDROGEN; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, ESTROGEN; RISK;

EID: 80053492091     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-10-88     Document Type: Article

References (83)

1. Cancer burden in the year 2000. The global picture. Parkin DM, Bray FI, Devesa SS, Eur J Cancer 2001 37 Suppl 8 4 66 11602373
2. Estimates of cancer incidence and mortality in Europe in 1995. Bray F, Sankila R, Ferlay J, Parkin DM, Eur J Cancer 2002 38 99 166 10.1016/S0959- 8049(01)00350-1 11750846 (Pubitemid 34031832)
3. Breast cancer in Greenland - selected epidemiological, clinical, and histological features. Nielsen NH, Hansen JP, J Cancer Res Clin Oncol 1980 98 287 299 10.1007/BF00410791 7228881 (Pubitemid 11197263)
4. Health Transitions in Arctic Populations, part four. Young TK, Bjerregaard P, eds, Toronto: University of Toronto Press, Toronto Buffalo London 2008
5. Founder mutations in BRCA1 and BRCA2 genes. Ferla R, Calo V, Cascio S, Rinaldi G, Badalamenti G, Carreca I, Surmacz E, Colucci G, Bazan V, Russo A, Ann Oncol 2007 18 Suppl 6 & 22i93 98 17591843
6. Breast Cancer in Europe. http://www.encr.com.fr/breast-factsheets.pdf
7. Breast Cancer Risk Factors. http://info.cancerresearchuk.org/cancerstats/ types/breast/riskfactors/
8. Proportion of breast cancer cases in the United States explained by well-established risk factors. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN, J Natl Cancer Inst 1995 87 1681 1685 10.1093/jnci/87.22.1681 7473816
9. Fetal origins of breast cancer. Hilakivi-Clarke L, de Assis S, Trends Endocrinol Metab 2006 17 340 348 10.1016/j.tem.2006.09.002 16997567 (Pubitemid 44584730)
10. Environmental exposure to polychlorinated biphenyls and breast cancer risk. Moysich KB, Menezes RJ, Baker JA, Falkner KL, Rev Environ Health 2002 17 263 277 10.1515/REVEH.2002.17.4.263 12611469 (Pubitemid 36222133)
11. Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case-controls study. Hoyer AP, Gerdes AM, Jorgensen T, Rank F, Hartvig HB, Breast Cancer Res Treat 2002 71 59 65 10.1023/A:1013340327099 11859874 (Pubitemid 34121817)
12. Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study. Hoyer AP, Jorgensen T, Rank F, Grandjean P, BMC Cancer 2001 1 8 10.1186/1471-2407-1-8 11518544 (Pubitemid 38846511)
13. Adipose organochlorine concentrations and risk of breast cancer among postmenopausal Danish women. Raaschou-Nielsen O, Pavuk M, Leblanc A, Dumas P, Philippe Weber J, Olsen A, Tjonneland A, Overvad K, Olsen JH, Cancer Epidemiol Biomarkers Prev 2005 14 67 74 15668478 (Pubitemid 40165285)
14. Environmental exposure to polychlorinated biphenyls (PCBs) and breast cancer: a systematic review of the epidemiological evidence. Negri E, Bosetti C, Fattore E, La Vecchia C, Eur J Cancer Prev 2003 12 509 516 10.1097/00008469- 200312000-00010 14639129
15. Properties of perfluorinated liquids. Sargent JW, Seffl RJ, Fed Proc 1970 29 1699 1703 5457573
16. Predicting the biodegradation products of perfluorinated chemicals using CATABOL. Dimitrov S, Kamenska V, Walker JD, Windle W, Purdy R, Lewis M, Mekenyan O, SAR QSAR Environ Res 2004 15 69 82 10.1080/1062936032000169688 15113070 (Pubitemid 38170956)
17. Global biomonitoring of perfluorinated organics. Giesy JP, Kannan K, Jones PD, ScientificWorldJournal 2001 1 627 629 12805763
18. Global distribution of perfluorooctane sulfonate in wildlife. Giesy JP, Kannan K, Environ Sci Technol 2001 35 1339 1342 10.1021/es001834k 11348064 (Pubitemid 32862501)
19. Hazard assessment of perfluorooctane sulfonate and its salts. OECD, ENV/JM/EXCH, 8, Paris, France 2002
20. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Olsen GW, Mair DC, Church TR, Ellefson ME, Reagen WK, Boyd TM, Herron RM, Medhdizadehkashi Z, Nobiletti JB, Rios JA, Butenhoff JL, Zobel LR, Environ Sci Technol 2008 42 4989 4995 10.1021/es800071x 18678038 (Pubitemid 351956443)
21. Fourth Meeting of the Conference of the Parties of the Stockholm Convention. http://chm.pops.int/
22. Perfluorinated compounds - exposure assessment for the general population in Western countries. Fromme H, Tittlemier SA, Volkel W, Wilhelm M, Twardella D, Int J Hyg Environ Health 2009 212 239 270 10.1016/j.ijheh.2008.04.007 18565792
23. Biological monitoring of polyfluoroalkyl substances: A review. Houde M, Martin JW, Letcher RJ, Solomon KR, Muir DC, Environ Sci Technol 2006 40 3463 3473 10.1021/es052580b 16786681 (Pubitemid 43830953)
24. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Fei C, McLaughlin JK, Tarone RE, Olsen J, Environ Health Perspect 2007 115 1677 1682 10.1289/ehp.10506 18008003
25. Level and Temporal Trend of Perfluoroalkyl Acids in Greenlandic Inuit. Long M, Bossi R, Bonefeld-Jorgensen EC, International Journal of Circumpolar Health 2011
26. Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS) and maternally reported developmental milestones in infancy. Fei C, McLaughlin JK, Lipworth L, Olsen J, Environ Health Perspect 2008 116 1391 1395 10.1289/ehp.11277 18941583
27. Maternal levels of perfluorinated chemicals and subfecundity. Fei C, McLaughlin JK, Lipworth L, Olsen J, Hum Reprod 2009 24 1200 1205 10.1093/humrep/den490 19176540
28. Maternal concentrations of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) and duration of breastfeeding. Fei C, McLaughlin JK, Lipworth L, Olsen J, Scand J Work Environ Health 2010 36 413 421 20200757
29. Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. Fei C, McLaughlin JK, Tarone RE, Olsen J, Am J Epidemiol 2008 168 66 72 10.1093/aje/kwn095 18460444 (Pubitemid 351881888)
30. The toxicology of perfluorooctanoate. Kennedy GL Jr, Butenhoff JL, Olsen GW, O'Connor JC, Seacat AM, Perkins RG, Biegel LB, Murphy SR, Farrar DG, Crit Rev Toxicol 2004 34 351 384 10.1080/10408440490464705 15328768 (Pubitemid 38888064)
31. Characterization of risk for general population exposure to perfluorooctanoate. Butenhoff JL, Gaylor DW, Moore JA, Olsen GW, Rodricks J, Mandel JH, Zobel LR, Regul Toxicol Pharmacol 2004 39 363 380 10.1016/j.yrtph.2004.03.003 15135214 (Pubitemid 38596771)
32. Perfluoroalkyl acids and related chemistries - toxicokinetics and modes of action. Andersen ME, Butenhoff JL, Chang SC, Farrar DG, Kennedy GL Jr, Lau C, Olsen GW, Seed J, Wallace KB, Toxicol Sci 2008 102 3 14 18003598 (Pubitemid 351250465)
33. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Lau C, Anitole K, Hodes C, Lai D, Pfahles-Hutchens A, Seed J, Toxicol Sci 2007 99 366 394 10.1093/toxsci/kfm128 17519394 (Pubitemid 351753056)
34. Behavioral effects in adult mice exposed to perfluorooctane sulfonate (PFOS). Fuentes S, Vicens P, Colomina MT, Domingo JL, Toxicology 2007 242 123 129 10.1016/j.tox.2007.09.012 17950980 (Pubitemid 350087436)
35. Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain. Johansson N, Eriksson P, Viberg H, Toxicol Sci 2009 108 412 418 10.1093/toxsci/kfp029 19211617
36. Determinants of Plasma PFOA and PFOS Levels Among 652 Danish Men (dagger). Eriksen KT, Sorensen M, McLaughlin JK, Tjonneland A, Overvad K, Raaschou-Nielsen O, Environ Sci Technol 2011 49 8137 8143
37. Draft risk assessment of potential human health effects associated with PFOA and its salts. U.S.EPA, US EPA SAB, May 30, 2006, USEPA public docket EPA-SAB-06-006, Washington, DC 2006
38. Final report of a two year oral (diet) toxicity and carcinogenicity study of fluorochemical FC-143 (perfluorooctanane ammonium carboxylate) in rats. Sibinski LJ, 3M Company/RIKER Exp No 0281CR0012; 8EHQ-1087-0394 1987 1 4
39. Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. White SS, Calafat AM, Kuklenyik Z, Villanueva L, Zehr RD, Helfant L, Strynar MJ, Lindstrom AB, Thibodeaux JR, Wood C, Fenton SE, Toxicol Sci 2007 96 133 144 17132714 (Pubitemid 46323216)
40. Evaluating human health risks from exposure to perfluorooctanoic acid (PFOA): Recommendations to the Science Advisory Board's PFOA Review Panel. Kropp T, Houlihan J, Presented February 10, 2005 to the US EPA Science Advisory Board's PFOA Review Panel, in Washington, DC 2005
41. Estrogen-like properties of fluorotelomer alcohols as revealed by mcf-7 breast cancer cell proliferation. Maras M, Vanparys C, Muylle F, Robbens J, Berger U, Barber JL, Blust R, De Coen W, Environ Health Perspect 2006 114 100 105 10.1289/ehp.8149 16393665 (Pubitemid 43056875)
42. Plasma organochlorine concentrations and bone ultrasound measurements: a cross-sectional study in peri-and postmenopausal Inuit women from Greenland. Cote S, Ayotte P, Dodin S, Blanchet C, Mulvad G, Petersen HS, Gingras S, Dewailly E, Environ Health 2006 5 33 10.1186/1476-069X-5-33 17184534 (Pubitemid 46178372)
43. Contaminants, diet, plasma fatty acids and smoking in Greenland 1999-2005. Deutch B, Pedersen HS, Asmund G, Hansen JC, Sci Total Environ 2007 372 486 496 10.1016/j.scitotenv.2006.10.043 17157358 (Pubitemid 46037786)
44. Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Phillips DL, Pirkle JL, Burse VW, Bernert JT Jr, Henderson LO, Needham LL, Arch Environ Contam Toxicol 1989 18 495 500 10.1007/BF01055015 2505694 (Pubitemid 19164069)
45. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Hansen KJ, Clemen LA, Ellefson ME, Johnson HO, Environ Sci Technol 2001 35 766 770 10.1021/es001489z 11349290 (Pubitemid 32173716)
46. AMAP Ring Test for Persistent Organic Pollutants in Human Serum. http://www.inspq.qc.ca/ctq/paqe/amap/rapports.asp
47. Very high concentrations of n-3 fatty acids in peri- and postmenopausal Inuit women from Greenland. Cote S, Dodin S, Blanchet C, Mulvad G, Pedersen HS, Holub BJ, Dewailly E, Int J Circumpolar Health 2004 63 Suppl 2 298 301 15736672
48. Dietary composition in Greenland 2000, plasma fatty acids and persistent organic pollutants. Deutch B, Pedersen HS, Hansen JC, Sci Total Environ 2004 331 177 188 10.1016/j.scitotenv.2004.03.028 15325148 (Pubitemid 39490370)
49. Adipose tissue fatty acids as biomarkers of dietary exposure in Danish men and women. Tjonneland A, Overvad K, Thorling E, Ewertz M, Am J Clin Nutr 1993 57 629 633 8480677 (Pubitemid 23132794)
50. SPE-HPLC purification of endocrine-disrupting compounds from human serum for assessment of xenoestrogenic activity. Hjelmborg PS, Ghisari M, Bonefeld-Jorgensen EC, Anal Bioanal Chem 2006 385 875 887 10.1007/s00216-006- 0463-9 16791568 (Pubitemid 350153363)
51. Xenoestrogenic activity in blood of European and Inuit populations. Bonefeld-Jorgensen EC, Hjelmborg PS, Reinert TS, Andersen BS, Lesovoy V, Lindh CH, Hagmar L, Giwercman A, Erlandsen M, Manicardi GC, Spano M, Toft G, Bonde JP, Environ Health 2006 5 12 10.1186/1476-069X-5-12 16674832 (Pubitemid 43938737)
52. Xeno-androgenic activity in serum differs across European and Inuit populations. Krüger T, Hjelmborg PS, Jönsson BAG, Hagmar L, Giwercman A, Manicardi G-C, Bizzaro D, Span M, Rignell-Hydbom A, Pedersen HS, Toft G, Bonde JP, Bonefeld-Jorgensen EC, Environmental Health Perspectives 2007 115 21 27 18174946
53. Effect of pesticides on estrogen receptor transactivation in vitro: A comparison of stable transfected MVLN and transient transfected MCF-7 cells. Bonefeld-Jorgensen EC, Grünfeld HT, Gjermandsen IM, Mol Cell Endocrinol 2005 244 20 30 10.1016/j.mce.2005.01.017 16219411 (Pubitemid 41628225)
54. Determinants of AhR-mediated transcriptional activity induced by plasma extracts from Nunavik Inuit adults. Medehouenou TC, Larochelle C, Dumas P, Dewailly E, Ayotte P, Chemosphere 2010 80 75 82 10.1016/j.chemosphere.2010.04. 017 20435334
55. Dioxin-like activities in serum across European and Inuit populations. Long M, Andersen BS, Lindh CH, Hagmar L, Giwercman A, Manicardi GC, Bizzaro D, Spano M, Toft G, Pedersen HS, Zvyezday V, Bonde JP, Bonefeld-Jorgensen EC, Environ Health 2006 5 14 10.1186/1476-069X-5-14 16725033 (Pubitemid 44071352)
56. Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. Garrison PM, Tullis K, Aarts JM, Brouwer A, Giesy JP, Denison MS, Fundam Appl Toxicol 1996 30 194 203 10.1006/faat.1996.0056 8812265 (Pubitemid 26115480)
57. Species-specific antagonism of Ah receptor action by 2,2',5,5'- tetrachloro- and 2,2',3,3'4,4'-hexachlorobiphenyl. Aarts JM, Denison MS, Cox MA, Schalk MA, Garrison PM, Tullis K, de Haan LH, Brouwer A, Eur J Pharmacol 1995 293 463 474 10.1016/0926-6917(95)90067-5 8748700 (Pubitemid 3006686)
58. Cancer in Greenlandic Inuit 1973-1997: a cohort study. Friborg J, Koch A, Wohlfarht J, Storm HH, Melbye M, Int J Cancer 2003 107 1017 1022 10.1002/ijc.11502 14601064 (Pubitemid 37429845)
59. The changing picture of neoplastic disease in the western and central Canadian Arctic (1950-1980). Hildes JA, Schaefer O, Can Med Assoc J 1984 130 25 32 6317154 (Pubitemid 14219044)
60. Breast cancer in Circumpolar Inuit 1969-1988. Miller AB, Gaudette LA, Acta Oncol 1996 35 577 580 10.3109/02841869609096989 8813064 (Pubitemid 26298452)
61. Prevalence of obesity and its metabolic correlates among the circumpolar inuit in 3 countries. Young TK, Bjerregaard P, Dewailly E, Risica PM, Jørgensen ME, Ebbesson SE, Am J Public Health 2007 97 691 695 10.2105/AJPH.2005.080614 17329661 (Pubitemid 47280168)
62. Adrenal androgens and human breast cancer: a new appraisal. Adams JB, Breast Cancer Res Treat 1998 51 183 188 10.1023/A:1006050720900 9879779 (Pubitemid 28561422)
63. Biomonitoring in Greenland: human biomarkers of exposure and effects-a short review. Bonefeld-Jorgensen EC, Rural Remote Health 2010 10 1362 20572746
64. Levels and trends of poly- and perfluorinated compounds in the arctic environment. Butt CM, Berger U, Bossi R, Tomy GT, Sci Total Environ 2010 408 2936 2965 10.1016/j.scitotenv.2010.03.015 20493516
65. Temporal and spatial trends of perfluorinated compounds in ringed seal (Phoca hispida) from Greenland. Bossi R, Riget FF, Dietz R, Environ Sci Technol 2005 39 7416 7422 10.1021/es0508469 16245810 (Pubitemid 41407469)
66. Increasing perfluoroalkyl contaminants in east greenland polar bears (Ursus maritimus): a new toxic threat to the Arctic bears. Dietz R, Bossi R, Riget FF, Sonne C, Born EW, Environ Sci Technol 2008 42 2701 2707 10.1021/es7025938 18505019 (Pubitemid 351485627)
67. Assessment of total effective xenoestrogen burden in adipose tissue and identification of chemicals responsible for the combined estrogenic effect. Fernandez MF, Rivas A, Olea-Serrano F, Cerrillo I, Molina-Molina JM, Araque P, Martinez-Vidal JL, Olea N, Anal Bioanal Chem 2004 379 163 170 10.1007/s00216-004-2558-5 15024544 (Pubitemid 40877637)
68. Breast cancer risk and the combined effect of environmental estrogens. Ibarluzea Jm J, Fernandez MF, Santa-Marina L, Olea-Serrano MF, Rivas AM, Aurrekoetxea JJ, Exposito J, Lorenzo M, Torne P, Villalobos M, Pedraza V, Sasco AJ, Olea N, Cancer Causes Control 2004 15 591 600 15280638 (Pubitemid 39070077)
69. Role of hormones in mammary cancer initiation and progression. Russo IH, Russo J, J Mammary Gland Biol Neoplasia 1998 3 49 61 10.1023/A:1018770218022 10819504 (Pubitemid 128513219)
70. Mixture effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and polychlorinated biphenyl congeners in rats. Chu I, Lecavalier P, Hakansson H, Yagminas A, Valli VE, Poon P, Feeley M, Chemosphere 2001 43 807 814 10.1016/S0045-6535(00)00437-9 11372869 (Pubitemid 32405533)
71. Antagonism of aryl hydrocarbon receptor-dependent induction of CYP1A1 and inhibition of IgM expression by di-ortho-substituted polychlorinated biphenyls. Suh J, Kang JS, Yang KH, Kaminski NE, Toxicol Appl Pharmacol 2003 187 11 21 10.1016/S0041-008X(02)00040-6 12628580 (Pubitemid 36293562)
72. Growth inhibitory and antimitogenic activity of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) in T47D human breast cancer cells. Fernandez P, Safe S, Toxicol Lett 1992 61 185 197 10.1016/0378-4274(92)90145-A 1322575
73. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and related compounds as antioestrogens: characterization and mechanism of action. Safe S, Astroff B, Harris M, Zacharewski T, Dickerson R, Romkes M, Biegel L, Pharmacol Toxicol 1991 69 400 409 10.1111/j.1600-0773.1991.tb01321.x 1766914
74. Mechanism of Action of TCDD as an Antiestrogen in Transformed Human Breast Cancer and Rodent Cell Lines. Safe S, Harris M, Biegel L, Zacharewski T, Banbury Report 35: Biological Basis for Risk Assessment of Dioxin and Related Compounds, 35 BR: Cold Spring Harbor Laboratory Press, 1991
75. Plasma concentrations of polychlorinated biphenyls and the risk of breast cancer: a congener-specific analysis. Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E, Am J Epidemiol 2002 155 629 635 10.1093/aje/155.7.629 11914190 (Pubitemid 34246095)
76. Selenium status in Greenland Inuit. Hansen JC, Deutch B, Pedersen HS, Sci Total Environ 2004 331 207 214 10.1016/j.scitotenv.2004.03.037 15325150 (Pubitemid 39490372)
77. Role of dietary fatty acids in mammary gland development and breast cancer. Maclennan M, Ma DW, Breast Cancer Res 2010 12 211 10.1186/bcr2646 21067551
78. N-3 and N-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case-control study in Tours, France. Maillard V, Bougnoux P, Ferrari P, Jourdan ML, Pinault M, Lavillonniere F, Body G, Le Floch O, Chajes V, Int J Cancer 2002 98 78 83 10.1002/ijc.10130 11857389 (Pubitemid 34113422)
79. The importance of N-6 and N-3 fatty acids in carcinogenesis. Kromhout D, Med Oncol Tumor Pharmacother 1990 7 173 176 2232934 (Pubitemid 20267986)
80. Trace elements and cancer risk: a review of the epidemiologic evidence. Silvera SAN, Rohan TE, Cancer Causes Control 2007 18 7 27 10.1007/s10552-006- 0057-z 17186419 (Pubitemid 46020898)
81. The effect of environment on breast cancer risk. Coyle YM, Breast Cancer Res Treat 2004 84 273 288 10.1023/B:BREA.0000019964.33963.09 15026625 (Pubitemid 38445377)
82. Traditional and modern Greenlandic food-Dietary composition, nutrients and contaminants. Deutch B, Dyerberg J, Pedersen HS, Aschlund E, Hansen JC, Sci Total Environ 2007 384 106 119 10.1016/j.scitotenv.2007.05.042 17629548 (Pubitemid 47285261)
83. Physiologically based pharmacokinetic modeling of persistent organic pollutants for lifetime exposure assessment: a new tool in breast cancer epidemiologic studies. Verner MA, Charbonneau M, Lopez-Carrillo L, Haddad S, Environ Health Perspect 2008 116 886 892 10.1289/ehp.10917 18629310 (Pubitemid 351943895)